A Rare Case of Acute Generalized Exanthematous Pustulosis in a Filipino Female Pediatric Patient with Systemic Lupus Erythematosus
DOI:
https://doi.org/10.70552/pjaai.24.2.14385Keywords:
acute generalized exanthematous pustulosis, systemic lupus erythematosus, acute generalized exanthematous pustulosis in systemic lupus erythematosus, AGEP, SLEAbstract
Acute generalized exanthematous pustulosis (AGEP) is a rare, febrile drug eruption characterized by non-follicular pustules and systemic involvement. Its features may overlap with systemic lupus erythematosus (SLE), complicating diagnosis and management. This study reports the first documented pediatric case of this complex disease phenomenon.
An 18-year-old Filipino female with newly diagnosed SLE on hydroxychloroquine presented with diffuse non-follicular pustules and fever after the initiation of azithromycin for upper respiratory tract infection. Histopathology examination revealed subcorneal pustules, which, together with clinical and dermoscopic findings, supported the clinical diagnosis of Definitive AGEP (EuroSCAR Score 11). Both identified high-risk drugs, hydroxychloroquine and azithromycin, were discontinued. Following drug withdrawal, corticosteroid, and supportive care, her clinical condition subsequently improved.
This report highlights the diagnostic challenge between AGEP and SLE. An interleukin-8-mediated mechanism appears to play a central role in bridging the pathogenesis of both conditions. Despite controversies, corticosteroids have proven to be an effective adjunct in the management of AGEP, while controlling the underlying SLE.
References
Kang S, ed. Fitzpatrick’s dermatology, vol. 2, 9th ed. New York: McGraw-Hill; 2019.
Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007;157(5):989-96. https://pubmed.ncbi.nlm.nih.gov/17854366 https://doi.org/10.1111/j.1365-2133.2007.08156.x DOI: https://doi.org/10.1111/j.1365-2133.2007.08156.x
Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol. 2001;28(3):113-9. https://pubmed.ncbi.nlm.nih.gov/11168761 https://doi.org/10.1034/j.1600-0560.2001.028003113.x DOI: https://doi.org/10.1034/j.1600-0560.2001.028003113.x
Villamin CA, Navarra SV. Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus. Mod Rheumatol. 2008;18(2):161-4. https://pubmed.ncbi.nlm.nih.gov/18311532 https://doi.org/10.1007/s10165-008-0029-0 DOI: https://doi.org/10.1007/s10165-008-0029-0
Sequeira JF, Cesic D, Keser G, et al. Allergic disorders in systemic lupus erythematosus. Lupus. 1993;2(3):187-91. https://pubmed.ncbi.nlm.nih.gov/8369810 https://doi.org/10.1177/096120339300200311 DOI: https://doi.org/10.1177/096120339300200311
Solhjoo M, Goyal A, Chauhan K. Drug-induced lupus erythematosus. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK441889/
Watanabe Y, Yamaguchi Y. Drug allergy and autoimmune diseases. Allergol Int. 2022;71(2):179-84. https://pubmed.ncbi.nlm.nih.gov/35219608 https://doi.org/10.1016/j.alit.2022.02.001 DOI: https://doi.org/10.1016/j.alit.2022.02.001
Errichetti E, Pegolo E, Stinco G. Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption. J Am Acad Dermatol. 2016;74(2):e29-31. https://pubmed.ncbi.nlm.nih.gov/26775791 https://doi.org/10.1016/j.jaad.2015.10.030 DOI: https://doi.org/10.1016/j.jaad.2015.10.030
Schaerli P, Britschgi M, Keller M, et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol. 2004;173(3):2151-8. https://pubmed.ncbi.nlm.nih.gov/15265952 https://doi.org/10.4049/jimmunol.173.3.2151 DOI: https://doi.org/10.4049/jimmunol.173.3.2151
Preclaro IA, Liwag KI, Tabalon-Morales M, Iniego-Rodas MC. Severe cutaneous adverse reactions: A narrative literature review. J Philipp Dermatol Soc. 2024;33(2):67–79. https://doi.org/10.4103/jpds.jpds_38_24 DOI: https://doi.org/10.4103/JPDS.JPDS_38_24
Crokaert F, Hubloux A, Cauchie P. A phase i determination of azithromycin in plasma during a 6-week period in normal volunteers after a standard dose of 500mg once daily for 3 days. Clin Drug Investig. 1998;16(2):161-6. https://pubmed.ncbi.nlm.nih.gov/18370534 https://doi.org/10.2165/00044011-199816020-00009 DOI: https://doi.org/10.2165/00044011-199816020-00009
Chaabouni R, Bahloul E, Ennouri M, et al. Hydroxychloroquine-induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature. Int J Dermatol. 2021;60(6):742-8. https://pubmed.ncbi.nlm.nih.gov/33598928 https://doi.org/10.1111/ijd.15419 DOI: https://doi.org/10.1111/ijd.15419
de Groot AC. Results of patch testing in acute generalized exanthematous pustulosis (AGEP): a literature review. Contact Dermatitis. 2022;87(2):119-41. https://pubmed.ncbi.nlm.nih.gov/35187690 https://doi.org/10.1111/cod.14075 DOI: https://doi.org/10.1111/cod.14075
Department of Dermatology - Region 1 Medical Center. Out-patient Department and Ward Census. Accessed March 3, 2025
Aouhab Z, Hong H, Felicelli C, Tarplin S, Ostrowski RA. Outcomes of systemic lupus erythematosus in patients who discontinue hydroxychloroquine. ACR Open Rheumatol. 2019;1(9):593-9. https://pubmed.ncbi.nlm.nih.gov/31777844 PMCID: PMC6857977 https://doi.org/10.1002/acr2.11084 DOI: https://doi.org/10.1002/acr2.11084
Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol. 2015;73(5):843-8. https://pubmed.ncbi.nlm.nih.gov/26354880 https://doi.org/10.1016/j.jaad.2015.07.017 DOI: https://doi.org/10.1016/j.jaad.2015.07.017
Vallejo-Yagüe E, Martinez-De la Torre A, Mohamad OS, Sabu S, Burden AM. Drug triggers and clinic of acute generalized exanthematous pustulosis (AGEP): a literature case series of 297 patients. J Clin Med. 2022;11(2):397. https://pubmed.ncbi.nlm.nih.gov/35054090 PMCID: PMC8780223 https://doi.org/10.3390/jcm11020397 DOI: https://doi.org/10.3390/jcm11020397
Ingen-Housz-Oro S, Hotz C, Valeyrie-Allanore L, Sbidian E, Hemery F, Chosidow O, Wolkenstein P. Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 at a single centre. Br J Dermatol. 2015;172(5):1455-7. https://pubmed.ncbi.nlm.nih.gov/25399843 https://doi.org/10.1111/bjd.13540 DOI: https://doi.org/10.1111/bjd.13540
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Manuel V. Mendoza, Jr., MD, MBA, FRSPH, Maritess P. Macaraeg, MD, Camelia Faye R. Tuazon, MD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
